Rallybio Corporation

NASDAQ: RLYB · Real-Time Price · USD
0.58
0.03 (6.23%)
At close: Aug 15, 2025, 12:06 PM

Rallybio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
636K n/a n/a n/a
Cost of Revenue
n/a 150K 167K 109K
Gross Profit
636K -150K -167K -109K
Operating Income
-60.5M -78.93M -67.88M -45.65M
Interest Income
4.22M 6.15M 1.96M 54K
Pretax Income
-57.77M -74.56M -65.58M -45.51M
Net Income
-57.77M -74.56M -66.49M -47.01M
Selling & General & Admin
19.63M 25.39M 27.2M 18.74M
Research & Development
41.51M 53.39M 40.69M 26.91M
Other Expenses
n/a n/a 342K 96K
Operating Expenses
61.13M 78.93M 67.88M 45.65M
Interest Expense
n/a n/a n/a 10K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
61.13M 78.93M 67.88M 45.65M
Income Tax Expense
-2.24M -2.04M n/a n/a
Shares Outstanding (Basic)
43.55M 40.45M 31.82M 32.13M
Shares Outstanding (Diluted)
43.55M 40.45M 31.82M 32.13M
EPS (Basic)
-1.33 -1.84 -2.09 -1.46
EPS (Diluted)
-1.33 -1.84 -2.09 -1.46
EBITDA
-60.5M -72.37M -65.41M -45.39M
EBIT
-60.5M -72.52M -65.58M -45.5M
Depreciation & Amortization
131K 150K 167K 109K